SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Caliper Technologies - CALP -- Ignore unavailable to you. Want to Upgrade?

To: tuck who wrote (98)8/17/2006 3:23:15 PM
From: tuck  Read Replies (1) | Respond to of 114
 
>>11:01AM Caliper Life Sciences unit Xenogen announced a target validation collaboration with Schering-Plough (CALP) 4.91 +0.31 : Xenogen Biosciences, acquired on August 9, 2006, by Caliper Life Sciences (CALP), today announces a target validation collaboration with Schering-Plough Corporation (SGP), under which Xenogen Biosciences will utilize its proprietary Serial Phenotyping Compression Technology to characterize high value targets resulting from drug discovery research conducted by the Schering-Plough Research Institute. Financial terms of the deal were not disclosed.<<

Courtesy Briefing.com

Cheers, Tuck



To: tuck who wrote (98)2/3/2007 1:45:45 PM
From: Steve Lokness  Read Replies (2) | Respond to of 114
 
Tuck;
Do you - or others - still follow CALP? Seems I remember your Mom had some?

They should have the XGEN integrated into their business by now? I still have my CALP shares (and warrants) from the XGEN acquisition and like how CALP has been looking from a technical basis. I have added just a little recently. Any thoughts?

steve


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News